Tools
Back to Results

Synta 9090-11


Title

Breast Cancer - Ganetespib Monotherapy In Women With Previously Untreated Breast Cancer

Therapeutic Area Breast Cancer
Principal Investigator John K. Erban, MD
Min Age 18 Years
Gender Female
Contact Jennifer Caplain
617-636-9161
More Information http://clinicaltrials.gov/ct2/show/NCT01677455

Overview

The purpose of this research study is to see if ganetespib could be a safe and effective treatment for advanced breast cancer.

Study Details

Inclusion Criteria

  • Invasive breast cancer
  • Stage IV disease
  • Adequate hamatological, hepatic, and renal functions

Exclusion Criteria

  • A new diagnosed subjects with HER2+ disease
  • Presence of active or untreated CNS metastases
  • Bone as the only site of metastatic disease from breast cancer

Study Requirements

Participants will be randomized to two groups. Group A includes HER2+ breast cancer participants and Group B includes triple negative breast cancer participants. Both groups will receive Ganetespib monotherapy. Participants will have medical exams, blood draws, PET/CT, MRI and other scans necessary for this study.

Nurse navigators for cancer patients at Tufts Medical Center.

Are you interested in learning more about this clinical trial?

Send us a message and we'll get back to you with more information.

Request information